References
- Maedler K, Donath MY. Beta-cells in type 2 diabetes: a loss of function and mass. Horm Res 2004;62:67-73
- Wright A, Burden AC, Paisey RB, et al. Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57). Diabetes Care 2002;25:330-6
- Holman RR, Paul SK, Bethel MA, et al. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med 2008;359:1577-89
- U.K. Prospective Diabetes Study Group. Quality of life in type 2 diabetic patients is affected by complications but not by intensive policies to improve blood glucose or blood pressure control (UKPDS 37). Diabetes Care 1999;22:1125-36
- Hunt LM, Valenzuela MA, Pugh JA. NIDDM patients’ fears and hopes about insulin therapy. Diabetes Care 1997;20:292-8
- Ratzmann K. The psychological aspects of diabetes with the secondary failure of sulfonylurea therapy. Dtsch Med Wochenschr 1991;116:87-90
- Polonsky WH, Richard AJ. What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in Type 2 Diabetes. Clin Diabetes 2004;22:147-50
- Polonsky WH, Fisher L, Guzman S, et al. psychological insulin resistance in patients with Type 2 Diabetes the scope of the problem. Diabetes Care 2005;28:2543-5
- Brod M, Kongsø JH, Lessard S, et al. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res 2009;18:23-32
- Funnell MM. Overcoming barriers to the initiation of insulin therapy. Clin Diabetes 2007;25:36-8
- Peyrot M, Rubin RR, Lauritzen T, et al. The International DAWN Advisory Panel. Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study. Diabetes Care 2005;28:2673-9
- Ishii H, Iwamoto Y, Tajima N. An exploration of barriers to insulin initiation for physicians in Japan: findings from the Diabetes Attitudes, Wishes and Needs (DAWN) JAPAN Study. PLoS One 2012;7:e36361
- World Medical Association. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Last amended by the 59th WMA General Assembly, Seoul, Korea. 2008
- Ministry of Education, Culture, Sports, Science & Technology and the Ministry of Health, Labor & Welfare. Ethical guidelines for epidemiological research. Tokyo: Ministry of Education, Culture, Sports, Science & Technology and the Ministry of Health, Labor & Welfare, 2002
- Wulff H. The two cultures of medicine: objective facts versus subjectivity and values. J R Soc Med 1999;92:549-52
- Nakar S, Yitzhaki G, Rosenberg R, et al. Transition to insulin in type 2 diabetes: family physicians’ misconceptions of patients’ fears contributes to existing barriers. J Diabetes Compl 2007;21:220-6
- Haque M, Emerson SH, Dennison CR, et al. Barriers to initiating insulin therapy in patients with type 2 diabetes mellitus in public-sector primary health care centres in Cape Town. S Afr Med J 2005;95:798-802
- Jeavons D, Hungin APS, Cornford CS. Patients with poorly controlled diabetes in primary care: healthcare clinicians’ beliefs and attitudes. Postgrad Med J 2006;82:347-50
- Leslie CA, Satin-Rapaport W. Psychological insulin resistance–a challenge for diabetes patients and health professionals. Today’s Therapeut Trend 1995;13:21-7
- Rubin RR, Peyrot M. Psychological issues and treatments in people with diabetes. J Clin Psychol 2001;57:457-8
- Funnell MM, Kruger DF, Spencer M. Self-management support for insulin therapy in type 2 diabetes. Diabetes Educ 2004;30:274-80
- Snoek J. Breaking the barriers to optimal glycaemic control – what physicians need to know from patients’ perspectives. Int J Clin Pract Suppl 2002;129:80-4
- Meece J. Dispelling myths and removing barriers about insulin in type 2 diabetes. Diabetes Educ 2006;32:9S-18S